Clinical Trial Update: Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluates the AIDA regimen (all-trans retinoic acid plus idarubicin) for treating acute promyelocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• All-trans retinoic acid (ATRA) (all-trans retinoic acid)
• Idarubicin (idarubicin)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Promyelocytic Leukemia | Phase 4 | Status: COMPLETED